Procter Gamble Stock Forum

Presentation children's depot

Hi,

as I have often seen the question of what is done for the children's custody account...

2 custody accounts with ING in the children's names,

150/month All World $VHYL (-0.09%) for up to 1000/year distribution

100/month S&P500 $VUSA (+1.03%) if the above target is reached, then €250

1x per year a relevant share, in the first year Procter and Gamble $PG (+3.31%)

Both portfolios identical

The bear in the pan goes crazy

I have reached my first major milestone and wanted to ask you what else you would add?

my idea was to add the $IWDA (+0.72%) ETF next year (after the $CSNDX (+0.78%) is full with 10000€ for now) 😈

Savings plans are currently running:

550€/month in the $CSNDX (+0.78%) ETF

100€/month in $KO (+1.1%)

100€/month in $PG (+3.31%)

the rest is purchased manually

Milestone 100k 💰

I didn't think I'd be able to break through the 100k mark this year, but I'm even happier about it now!

Within the next few days I will $PG (+3.31%) , $JNJ (+0.03%) and the $INRG (-2.09%) and sell the $IWDA (+0.72%) and shift most of it into the Then I will be completely satisfied with my current positions and almost 100% invested.

If you have any feedback, please let me know :)

Earnings next week 🗓️

$WBA (-1.4%)

$UNH (+3.09%)

$BAC (+1.3%)

$C (+1.33%)

$JNJ (+0.03%)

$GS (+2.22%)

$SCHW (+2.16%)

$UAL (+3.22%)

$ASML (-0.38%)

$MS (+1.35%)

$ABT (+2.48%)

$TSM (+0.91%)

$NFLX (+0.37%)

$ISRG (+2.71%)

$AXP (+0.52%)

$PG (+3.31%)

Unpopular trades Part I

$PG (+3.31%)

$HIMS (-0.18%)

Today I sold Procter & Gamble and practiced buy the dip with Hims & Hers.😎

Hello to all investors!

Today I would like to draw your attention to the share $MC (-2.6%) and my corresponding analysis. The price reversed in the "yellow zone" that I had forecast. We are currently moving back towards the large price gap of September 26. In this zone, it could be worthwhile adding to positions.

Furthermore $V (+1.22%) convinced me today with a pleasing price increase and stable volume. $NOVO B (+0.73%) is also well on the way to reaching my first buying point. $PG (+3.31%) On the other hand, the price has not yet shown the desired behavior and is still waiting.

Your duck

Good evening everyone,

The first steps have been taken. I sold the following shares today:

$KMB (+1.82%) A weak underperformer that operates in a business sector with a poor stomach.

I simply don't see any significant growth opportunities here over the next few years. I'd rather put the money into my broadly diversified world ETF or other investments. I got out with just under +10 %.

$PAYX (+2.17%) Out with around 6.5 % and the reasons for the sale are largely the same as for Kimberly-Clark.

$MSTR (+1.77%) After the rapid rise of the last few weeks, this has become too risky for me. I got out after a short holding period with around 28%.

In addition, the correlation with Bitcoin is very strong. And I'd rather hold my own $BTC (+0.41%) . From another perspective, if the value of the Bitcoin held is roughly half the market capitalization and you ignore the high level of debt, I still don't know where the other half of the market capitalization comes from.

The dividend aristocrat Procter & Gamble was actually also on the hit list for today $PG (+3.31%) Ecolab $ECL (+2.32%) and Colgate $CL (+3.18%) . I'm still not 100% sure about these, hence the vote. I would like to take a closer look. I was particularly fascinated by the 12m chart for Colgate. It looks as if a child has drawn a straight line from bottom left to top right. It's similar with Ecolab, where they have made around 45% in twelve months with dividends. (With Colgate around 40 %)

What happens next? The portfolio will be further reduced/concentrated. The BDCs are high on the hit list $ARCC (+1.62%)
$MAIN (+0.69%)
$HTGC (+0.27%)

REITs, on the other hand, can stay, as they currently have strong momentum and could benefit from falling interest rates. The only one I'm not quite sure about yet and would like to take a closer look at fundamentally when the opportunity arises is $STAG (+0.87%)

Hello everyone,

this is my first post on this site and I would like to share my analysis of today's $PG (+3.31%) with you today. I hope I was able to help you with this.

Technical analysis:

Procter & Gamble has been in a longer-term uptrend since December 2023. This began after a false breakout to the downside during the consolidation phase (April-December 2023) and was confirmed by the break through the last high. In September 2024, we saw another breakout from a consolidation phase, this time to the upside. I also regard this as a false breakout, as the move was quickly corrected by two strong red candles. We are currently in a short-term downtrend that is increasingly approaching the lower limit of the consolidation phase.

The 9-day moving average crossed the 21-day moving average yesterday, giving a bearish signal - but not yet meaningful on its own. However, these lines will soon cross on the weekly chart as well, which is of greater importance to me. The exponential moving averages of the last 20, 50, 100 and 200 days are also beginning to flatten out and point downwards.

The first minor confirmation of my theory should come this week if the €152.7 level is broken to the downside. A stronger and more important confirmation would come if the level of € 150.60 - the lower limit of the consolidation phase - is broken. Based on the last important lows and a fair value gap, I see three potential buy zones.

All in all, the technical analysis gives me a bearish signal.

Multiples:

EV/EBITDA values of the last 15 years:

Current EV/EBITDA value of Procter & Gamble: 19.16

Industry median for consumer goods companies: 10.7

It can be seen that P&G achieves an above-average valuation compared to its competitors and the industry median.

We also recognize that the current value is above average when compared to the highest values of the last few years and the median values of the highest years.

In summary, we recognize a possible overvaluation, but this alone is not sufficient to expect prices to fall. Nevertheless, my personal weighting of the above values leads me to the following conclusion:

WORST CASE: ~13.5

BUY: ~14.00

SELL: ~18.60

(These values are based on a long-only strategy. If you also sell short, SELL is indicated as follows: >18.60)

Price/sales values of the last 15 years:

Current P/S value of Procter & Gamble: 4.89

Industry median for consumer goods companies: 3.04

Here, too, it can be seen that P&G is rated above average compared to its competitors and the industry median.

Compared to the mean values of the last three years (also the highest three years), we are even above average here.

In summary, we recognize a possible overvaluation, but this alone is not sufficient to expect prices to fall. Nevertheless, my personal weighting of the above values leads me to the following conclusion:

WORST CASE: ~3.25

BUY: ~3.70

SELL: ~4.80

(These values are based on a long-only strategy. If you also sell short, SELL is indicated as follows: >4.80)

Financial analysis:

Sales growth:

• On an annual basis, P&G showed consistent sales growth of around 4-5%, mainly due to price increases and strong demand in key markets.
• On a quarterly basis, sales figures were also stable, but fluctuated slightly due to seasonality and currency effects. In the last quarter, a slight decline in organic sales was observed in certain international markets, but this was offset by price adjustments.

Earnings (profits):

• Earnings on an annualized basis have steadily increased in recent years. P&G has seen an improvement in gross margin due to efficiency measures and cost controls.
• On a quarterly basis, there are some fluctuations, particularly due to raw material costs and currency effects, which have impacted profit margins. Nevertheless, net profits remain at a healthy level due to the company's ability to manage costs effectively and pass on price increases.

Conclusion:

Based on the combination of the results of the fundamental and technical analysis, I come to the following conclusion:

Procter & Gamble could see a small correction in the near future, possibly reaching the final zone of 138-139.5€. This correction is unlikely to be long-lasting or have a lasting effect. In the short term, my assessment of this share therefore remains negative for the time being. The best chance of a good return is to make several partial entries into the share, the zones of which are marked in the chart.

Personal entry strategy:

1/3 of the planned investment amount* at € 146.30

1/3 of the planned investment amount at € 143.45

1/3 of the planned investment amount at € 138

*(= total amount that you would like to invest in the share)

#proctergamble
#konsumgüter
#usa